Kinetics of polymorphic behavior in supercooled melting of 1- (5-Oxo-hexyl) -theobromine
Eckert, T.; Müller, J.
Pharmaceutica Acta Helvetiae 52(3): 45-47
1977
ISSN/ISBN: 0031-6865 PMID: 918127 Document Number: 124228
Document emailed within 1 workday
Related Documents
Borka, L. 1974: The polymorphism of indomethacine. new modifications, their melting behavior and solubility Acta Pharmaceutica Suecica 11(3): 295-303Cannon, A.J.; Trappler, E.H. 2000: The influence of lyophilization on the polymorphic behavior of mannitol PDA Journal of Pharmaceutical Science and Technology 54(1): 13-22
Büchi, J.; Hasler, C. 1974: Reference compounds for determination of melting temperature according to Ph. Helv. VI and Ph. eur. I. 4. Determination of purity and melting point with differential scanning calorimetry--results and discussion Pharmaceutica Acta Helvetiae 49(3-4): 102-107
Tarka, S.M.; Zoumas, B.L.; Gans, J.H. 1979: Short-term effects of graded levels of theobromine in laboratory rodents Toxicology and Applied Pharmacology 49(1): 127-149
Bucher, H.U.; Gautschi, K. 1985: Detection of caffeine, theophylline and theobromine in the umbilical cord blood and breast milk Helvetica Paediatrica Acta 40(2-3): 163-167
Hinze, H.J. 1972: Pharmacokinetics of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191) in man Arzneimittel-Forschung 22(9): 1492-1495
Fabre, J.; Milek, E.; Kalfopoulos, P.; Mérier, G. 1971: Kinetics of tetracyclines in human. II. Excretion, penetration into normal and inflammed tissues, behavior in a case of renal insufficiency and in hemodialysis Schweizerische Medizinische Wochenschrift 101(18): 625-633
Jovanović, U.J. 1972: Polygraphic registrations after parenteral administration of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191) Arzneimittel-Forschung 22(6): 994-999
Boksay, I.; Bollmann, V.; Popendiker, K. 1971: Influence of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine on alpha-adrenergic effects Arzneimittel-Forschung 21(8): 1174-1177
Campbell, M.E.; Grant, D.M.; Inaba, T.; Kalow, W. 1987: Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes Drug Metabolism and Disposition: the Biological Fate of Chemicals 15(2): 237-249
Maillard, C.; Ollivier, B.; Balansard, G.; De Meo, M. 1986: Assay of caffeine, theobromine, catechin and epicatechin by high performance liquid chromatography in an extract of fresh stabilized cola seeds Annales Pharmaceutiques Francaises 44(6): 495-500
Santhosh, A.; Lakshmi, L.R.; Arun, P.; Deepadevi, K.V.; Nair, K.G.; Manojkumar, V.; Kurup, P.A. 1998: Synthesis of NAD+ in erythrocytes incubated with nicotinic acid and the effect of di-(2-ethyl hexyl) phthalate (DEHP) Indian Journal of Biochemistry and Biophysics 35(4): 236-240
Chiou, C.Y.; Malagodi, M.H.; Sastry, B.V.; Posner, P. 1976: Effects of calcium antagonist, 6-(N, N-diethylamino) hexyl-3, 4, 5-trimethoxybenzoate, on digitalis-induced arrhythmias and cardiac contractions Journal of Pharmacology and Experimental Therapeutics 198(2): 444-449
Köhler, M. 1973: Muscular blood flow during inhibition of 3', 5'-AMP-phosphodiesterase. Clinical and experimental studies using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine Arzneimittel-Forschung 23(4): 566-570
Santhosh, A.; Nair, K.G.; Arun, P.; Deepadevi, K.V.; Manojkumar, V.; Lakshmi, L.R.; Kurup, P.A. 1998: Effect of DEHP [di-(2-ethyl hexyl) phthalate] on lipid peroxidation in liver in rats and in primary cultures of rat hepatocytes Indian Journal of Medical Research 108: 17-23
Akiharu, W.; Higashi, T.; Kobayashi, M.; Nakatsukasa, H.; Fujiwara, M.; Shiota, T.; Yamauchi, Y.; Ito, T.; Yamamoto, H.; Nagashima, H. 1984: Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(12 Part 1): 2506-2512
Meyer, C.R. 2012: Medicine and the melting pot Minnesota Medicine 95(5): 4
Futakuchi, M.; Hirose, M.; Miki, T.; Tanaka, H.; Ozaki, M.; Shirai, T. 1998: Inhibition of DMBA-initiated rat mammary tumour development by 1-O-hexyl-2,3,5-trimethylhydroquinone, phenylethyl isothiocyanate, and novel synthetic ascorbic acid derivatives European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 7(2): 153-159
Pawelczyk, E.; Zajac, M.; Matlak, B. 1976: Kinetics of drug decomposition. Part 37. Kinetics of autoxidation of narcotine in aqueous solutions Polish Journal of Pharmacology and Pharmacy 28(1): 69-76
Pawełczyk, E.; Zajac, M.; Knitter, B.; Mikołajczak, P. 1981: Kinetics of drug decomposition. Part 66. Kinetics of the hydrolysis of carphecillin in aqueous solution Polish Journal of Pharmacology and Pharmacy 33(3): 373-386